Table 1. Baseline quantitative characteristics of the training set and validation set.
| Variables | Training set (N = 290) | Validation set (N = 70) | P-Value |
| Donor characteristics | |||
| D-Age (yr) | 38.12±12.33 | 37.88±11.99 | 0.883 |
| D-BMI | 23.95±5.84 | 24.89±5.16 | 0.218 |
| cold ischemia times (hour)* | 8.65±4.16 | 8.92±4.03 | 0.624 |
| warm ischemia times (min)* | 9.67±2.78 | 9.26±2.65 | 0.265 |
| Recipient characteristics | |||
| Age (yr) | 45.25±10.32 | 44.88±10.18 | 0.787 |
| BMI | 20.06±4.41 | 20.18±4.35 | 0.838 |
| HB (g/dl) | 9.58±5.36 | 9.03±5.11 | 0.437 |
| WBC (×109) | 6.36±4.66 | 7.05±4.69 | 0.268 |
| PLT (×109) | 83.86±85.58 | 79.99±81.56 | 0.732 |
| ALB (g/dl) | 3.06±0.65 | 2.89±0.55 | 0.044 |
| TB (mg/dl) | 13.81±14.66 | 12.39±13.46 | 0.461 |
| ALK (u/l) | 161.46±186.61 | 172.11±185.32 | 0.668 |
| GGT (u/l) | 102.87±184.35 | 97.56±173.23 | 0.827 |
| AST (u/l) | 124.62±176.05 | 149.76±175.69 | 0.284 |
| ALT (u/l) | 113.06±191.98 | 143.25±183.21 | 0.234 |
| BUN (mmol/l) | 20.55±16.86 | 21.02±16.36 | 0.833 |
| Crea (mg/dl) | 1.19±1.16 | 1.26±1.15 | 0.650 |
| APTT (s) | 57.93±25.69 | 62.57±25.43 | 0.175 |
| INR | 2.15±1.28 | 2.49±1.26 | 0.046 |
| Na+ (mmol/l) | 130.97±9.65 | 129.56±9.47 | 0.272 |
| SOFA scores* | 8.69±1.76 | 8.72±1.68 | 0.897 |
*
Ischemia times and recipients' SOFA scores were not used as candidate factors. BMI = body mass index; HB = hemoglobin; WBC = white blood cell; PLT = platelet; BUN = blood urea nitrogen; Crea = creatinine; ALB = albumin; TB = total bilirubin; ALK = alkaline phosphatase; GGT = γ-glutamyltransferase; AST = aspertate aminotransferase; ALT = alanine aminotransferase; INR = international normalized ratio of prothrombin time; APTT = activated partial thromboplastin time; Na+ = serum sodium; N/A = not applicable.